ArticlePharmaceutics2025

Development and Characterization of a New Oral Antileishmanial Bis(pyridine-2-Carboxamidine) Drug Through Innovative Dissolution Testing in Biorelevant Media Combined with Pharmacokinetic Studies.

Almudena Laguna et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.